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Edited by Hans EklundAbstract We determined the ﬁrst structure of PRYSPRY, a
domain found in over 500 diﬀerent proteins, involved in innate
immune signaling, cytokine signaling suppression, development,
cell growth and retroviral restriction. The fold encompasses a
7-stranded and a 6-stranded antiparallel b-sheet, arranged in a
b-sandwich. In the crystal, PRYSPRY forms a dimer where
the C-terminus of an acceptor molecule binds to the concave sur-
face of a donor molecule, which represents a putative interaction
site. Mutations in the PRYSPRY domains of Pyrin, which are
responsible for familial Mediterranean fever, map on the puta-
tive PRYSPRY interaction site.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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In 1997, sequence alignment studies [1] revealed a protein
domain present in many phylae, from yeast to human. This do-
main was named SPRY because it occurs in a Dictyostelium
discoideum dual-speciﬁcity kinase termed splA and in ryano-
dine receptor subtypes. Homologous sequences to the SPRY
domain were also discovered independently and the family
was named B30.2-like domain family [2].
Currently there is no structural information available for
this domain although it was found in more than 500 diﬀerent
proteins that can be classiﬁed into ﬁve families (Fig. 1). The
SPRY domain is present for example in butyrophilin-related
transmembrane glycoproteins (BTN) [3] and in stonustoxin
SNTX, a cytolytic secreted protein [4]. Another set of proteins
containing a SPRY domain are SSB proteins (SPRY domain
associated with a SOCS box) belonging to the family of sup-
pressors of cytokine signaling (SOCS) [5]. Recently it was
shown that SSBs bind target proteins and mediate their ubiq-
uitination which is followed by degradation [6]. Another large
and diverse family of proteins containing RING-ﬁnger motifs,
zinc-binding B-box motifs and a-helical coiled-coil domains,
known as the RBCC family, was found to carry a C-terminal
SPRY domain [7,8]. Proteins from the RBCC family are*Corresponding author. Fax: +41 44 635 68 34.
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regulation and diﬀerentiation [9,10]. They can be divided into
several subfamilies. One of these subfamilies is the tripartite
motif (TRIM) protein family [11]. Through a systematic
expression analysis of TRIM genes it was found that the com-
mon function shared by these proteins is the identiﬁcation of
speciﬁc cell compartments by means of homo-multimerization.
One family member, TRIM5a, has been identiﬁed to be
involved in HIV-1 restriction [12]. Very recently, it was shown
that TRIM5a from rhesus monkey can restrict HIV-1 replica-
tion [13] and that a single amino acid substitution located on
the SPRY domain of human TRIM-5a can also confer this
ability [14].
In the last years evidence accumulated that a newly identiﬁed
family of genes, called the PYRIN family, is involved in several
hereditary diseases, among them the familial Mediterranean
fever syndrome (FMF) [15]. Periodic fever syndromes are
autoinﬂammatory disorders, characterized by recurrent at-
tacks of systemic inﬂammatory reactions without an infection
or autoimmunity. In 1997 the gene responsible for FMF was
identiﬁed and named MEFV [16]. It codes for the protein
called Pyrin (Marenostrin), which belongs to the RBCC family
and contains a PRYSPRY-domain [7]. It could be shown that
mutations in the PRYSPRY-domain are responsible for the
FMF syndrome.
What is generally referred to as the SPRY domain in the lit-
erature is in fact a PRY segment of 61 amino acids followed by
a 139 amino acid-long SPRY segment (UniProt, [17]). We will
use here the name ‘‘PRYSPRY-domain’’ for the approxi-
mately 200 amino acid-long homologous sequences found in
all above mentioned proteins. The presence of the PRY-
SPRY-domain in functionally unrelated proteins may indicate
that the domain serves diﬀerent functions. Although the
sequence identity between PRYSPRY-domains in the de-
scribed protein families is low (around 20%) secondary struc-
ture prediction methods suggest that the domain consists of
15 b-strands and has an immunoglobulin-like fold [7].
Since this domain plays a role in innate immune signaling we
decided to elucidate its structure. The human gene of the PRY-
SPRY-19q13.4.1 domain, here simply referred to as the PRY-
SPRY-domain, is located on chromosome 19 between the
NALP9 and NALP11 genes. In this paper, we describe the
structure of this domain, its relationship to other homologous
domains and we discuss where mutations responsible for FMF
and HIV restriction map in PRYSPRY homology models of
Pyrin and TRIM5a.blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic drawing of the domain structure of ﬁve diﬀerent families of proteins containing a SPRY domain ordered according to the time of
their discovery (oldest on top).
100 C. Gru¨tter et al. / FEBS Letters 580 (2006) 99–1062. Materials and methods
2.1. Protein expression and puriﬁcation
The human PRYSPRY-domain of the gene 19q13.4.1 (Est number
CA454993, residues 1–201) was expressed in Escherichia coli
BL21(DE3) cells. Selenomethionine-labeled GST tagged PRYSPRY
was prepared in M9 media supplemented with speciﬁc amino acids
[18] at 37 C. 20 min before induction with 1 mM of IPTG, L-seleno-
methionine (50 mg/l) was added and the cells were grown for an addi-
tional 24 h at 20 C. The protein was extracted from the soluble
fraction of lysed cells using a glutathione sepharose column (Amer-
sham Biosciences) and then incubated overnight at room temperatureTable 1
Statistics for MAD data collection and structure determination of PRYSPR
Peak Inﬂection
Data collection
Wavelength (A˚) 0.9786 0.9793
a, b, c (A˚) 77.02, 77.02, 296.92 77.07, 77.07, 29
Resolution (A˚) 20–2.78 (2.88–2.78) 20–2.78 (2.88–2
Rsym 9.5 (26.7) 10.5 (28.0)
I/r(I) 13.3 (7.3) 13.3 (6.7)
Completeness (%) 98.8 (99.4) 98.7 (99.4)
Redundancy 5.1 (4.7) 5.1 (4.9)
Reﬁnement
Resolution (A˚)
No. reﬂections (work/test)
Rwork/Rfree (%)
No. of residues
No. of water molecules
RMS deviation bond lengths (A˚)
RMS deviation bond angles ()
Ramachandran plot
Residues in most favoured regions (%)
Residues in additional allowed regions (%)
Residues in generously allowed regions (%)
Ramachandran outliers (%)with recombinant/GST-tagged PreScission Protease (Amersham Bio-
sciences) to cleave the GST moiety. The protein was further puriﬁed
using ion exchange chromatography which yielded highly pure PRY-
SPRY.
2.2. Biochemical and biophysical characterization
2.2.1. Investigation of the solution state of PRYSPRY. Dynamic
light scattering measurements at 25 and 4 C on a DynaPro Titan
(Wyatt Technology) revealed for a concentrated PRYSPRY-solution
(25 mg/ml) a hydrodynamic radius of 2.6 nm with a polydispersity of
20–25%. For a diluted sample (2 mg/ml) the hydrodynamic radius
and the polydispersity decreased to 2.3 nm and 17%, respectively.Y (P4122)
Remote ‘‘Native’’
0.9001 0.8999
6.95 77.06, 77.06, 296.04 77.22, 77.22, 297.30
.78) 20–2.78 (2.88–2.78) 34–2.52 (2.61–2.52)
8.1 (41.2) 8.1 (50.2)
9.7 (3.8) 16.1 (3.1)
97.0 (98.9) 96.4 (99.0)
3.5 (3.5) 4.3 (4.3)
30.46–2.52
30329/1502
22.7/27.6
775
243
0.009
1.8
83
16
1
0
Fig. 2. (A) PRYSPRY topology cartoon. The ﬁrst 61 residues correspond to the PRY segment (blue box) and the last 139 residues correspond to the
SPRY segment (red box). (B) Stereo view of a ribbon representation of the PRYSPRY-domain. The PRY segment is colored in blue and the SPRY
segment is colored in red.
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Amersham Biosciences) showed the presence of monomeric (approx.
23 kDa) and dimeric (approx. 48 kDa) species. The protein was eluted
with 50 mM Tris–HCl (pH 7.0), 150 mM NaCl, 1 mM EDTA, 0.5 mM
TCEP at 4 C.
2.2.2. Crystallization of PRYSPRY. Selenomethionine-incorpo-
rated PRYSPRY was crystallized by vapor diﬀusion at 4 C against
a well solution containing 0.1 sodium cacodylate–AcOH (pH 6.5),
0.55 M KSCN, 25% (v/v) PEG 2000 MME using the sitting drop tech-
nique. Crystals of suitable size were obtained after 7 days. The crystals
belong to the tetragonal space group P4122, with cell dimensions
a = b = 77.22 A˚ and c = 297.30 A˚.
2.3. Data collection and structure determination
A multiple wavelength anomalous dispersion (MAD) dataset to 2.8-
A˚ resolution (Table 1) was collected from a single crystal of selenome-
thionine-labelled PRYSPRY at the X06SA beamline of the Swiss Light
Source (PSI, Villigen, Switzerland). A further dataset was collected at
2.5-A˚ resolution from another single crystal. Data were integrated with
DENZO [19], scaled with SCALEPACK [19] and further processed using
the CCP4 package [20].
The structure of PRYSPRY was solved with SHELX [21] and Auto-
Sharp [22]. The four molecules in the asymmetric unit were manually
completed and rebuilt using the program O [23]. The model was reﬁnedwith CNS [24] to a ﬁnal resolution of 2.5 A˚ with Rcryst/Rfree = 22.9/
27.9%. Model geometry and stereochemistry were checked with
PROCHECK [25]. The coordinates were deposited at the Protein Data
Bank (PDB ID: 2FBE).
2.3.1. Alignment and mutation models. Sequences were aligned
using ClustalX [26]. Model structures of the Pyrin and the TRIM5a
PRYSPRY-domain were created with MODELLER [27] using the
PRYSPRY structure as a template and the alignment described above.3. Results and discussion
3.1. Structure determination of PRYSPRY
The structure of PRYSPRY was solved by MAD and re-
ﬁned at 2.5 A˚ resolution with Rwork/Rfree values of 22.9%
and 27.9%, respectively. Crystallographic statistics are given
in Table 1.
The asymmetric unit contains four molecules that form two
nearly identical pairs of dimers. Nine residues of the C-termi-
nus of the ﬁrst PRYSPRY bind to the surface of a second
PRYSPRY molecule (Fig. 3A). The ﬁnal model contains
Fig. 3. (A) Stereo view of a ribbon and surface diagram of two interacting PRYSPRY domains. The acceptor molecule appears in blue and the
donor molecule in orange. (B) Ribbon diagram of the PRYSPRY dimer in comparison with pea lectin showing the position of a bound mannose (in
CPK orange) in the binding site (PDB code 1RIN). Pea lectin is represented in the same orientation as the acceptor PRYSPRY-domain. (C) Stereo
view of the interaction of the donor C-terminal tail with the acceptor molecule. (D) Stereo view of the interaction between Trp 122 and Pro 120 of the
acceptor molecule with Pro 2, Tyr 144, Val 146, Gly 149 and Phe 8 of the donor molecule.
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Table 2
The 10 ﬁrst hits from DALI server sorted by Z-scorea
No. PDB identiﬁer Name and reference Z-scorea RMSD Ca (A˚)b %Identityc Topology
1 1gv9 chain A Carbohydrate binding p58/ERGIC-53 fragment [30] 10.0 3.4 7 Sequentiald
2 1yif chain A b-1,4-Xylosidase (to be published) 8.8 3.7 4 Sequential
3 1led Lectin IV [33] 8.8 3.4 5 Sequential
4 1dyp chain A j-Carrageenase fragment [34] 8.8 3.4 8 Sequential
5 1utw chain A b-Fructosidase (Invertase) [35] 8.7 2.7 3 Sequential
6 1umz chain A Xyloglucan endotransglycosylase [36] 8.7 3.1 4 Sequential
7 1vav chain A Alginate lyase pa1167 (to be published) 8.1 3.6 8 Sequential
8 1ups chain A Glcnac-a-1,4-gal-releasing endo-b-galactosidase [37] 8.1 3.1 6 Sequential
9 1mz5 chain A Sialytransferase fragment [38] 7.9 3.4 12 Sequential
10 1lcl Lysophospholipase [39] 7.9 2.8 4 Sequential
aZ-score: standard normal distribution of the distance matrix comparison scores between two molecules (shape similarity).
bRMSD Ca: positional root mean square deviation of superimposed Ca atoms in Angstroms.
c%Identity: percentage of sequence identity over equivalenced positions.
dSequential: sequential connectivity of equivalenced fragments with no fragments matching in reversed chain direction and with no topological
permutations (loop reconnections between query and matched structure).
C. Gru¨tter et al. / FEBS Letters 580 (2006) 99–106 103residues 1 to 188/190 for acceptor molecules 1 and 3 and resi-
dues 1 to 198/199 for donor molecules 2 and 4. The unbound
C-terminal residues 189/191–201 of molecules 1 and 3 as well
as the residues 199/200 to 201 of molecules 2 and 4 are not vis-
ible in the electron density map.
3.2. Fold and overall structure of PRYSPRY
The PRYSPRY-domain has a jellyroll b-sandwich fold con-
sisting of a convex 7-stranded antiparallel b-sheet and a con-
cave twisted 6-stranded antiparallel b-sheet packed against
each other. The two b-sheets form a central ﬂat and elongated
hydrophobic core. The 13-stranded b-sandwich structure repre-
sents one compact domain and is not divided into a N-terminal
PRY domain and a C-terminal SPRY domain (UniProt, [17]).
The PRY segment of the structure starts with a long loop of
22 residues and continues with three b-strands (b1 to b3 of the
b-sandwich, Fig. 2). The SPRY segment consists of 10 b-
strands continuing the b-sandwich fold. The strands are con-
nected by loops of varying length. For a donor molecule the
C-terminal part of PRYSPRY continues in a loop-like fashion
and enters the binding site of an acceptor molecule with resi-
due 190 forming a small a-helix before it leaves the binding site
at residue 197.
The binding site is located on the concave side of the b-sand-
wich of the acceptor molecule. It is formed by the concave
twisted 6-stranded antiparallel b-sheet and is further deﬁned
by the end of loop2 (residues 50–53, PRY) and loops 5–7
and 12 (SPRY, Figs. 2A, 3A). The interactions with the
C-terminal tail of the donor molecule B are mainly mediated
by main chain–main chain hydrogen bonds (Fig. 3C). In addi-
tion Pro 120 and Trp 122, located at the entrance of the bind-
ing pocket, interact with a hydrophobic region of the donor
molecule (Pro 2, Phe 8, Tyr 144, Val 146 and Gly 149,
Fig. 3D). The complementarity of the interacting surfaces is
70% (surface area of 701 A˚2 for the donor and 812 A˚2 for
the acceptor molecule) corresponding to interactions seen in
antibody/antigen complexes [28]. Thus, PRYSPRY is probably
capable to interact with putative target proteins oﬀering a
donor strand with a diﬀerent sequence.
These interactions aﬀect the entire structure of the donor
molecule. Superposition of the donor and acceptor molecule
reveals an RMSD of 1.7 A˚. Most of the diﬀerences are located
around the binding site. Upon peptide binding the b-strands 2
(PRY) and 13 (SPRY) slightly rearrange opening the hydrogenbond between Ser 34 N (PRY segment) and Asn 177 C‚O
(SPRY segment).
As a consequence the C-terminus of the acceptor molecule
rearranges so that it cannot bind to a third molecule. The bind-
ing molecule itself cannot accept a further molecule because
the conformations of the N- and C-termini are ﬁxed. Thus
the aggregation stops at the dimer state.
We further investigated the quarternary structure of PRY-
SPRY in solution by dynamic light scattering and gel ﬁltration.
Both methods reveal monomeric and dimeric species for high
protein concentrations (25 mg/ml), and only monomers at
low concentrations (2 mg/ml) showing that PRYSPRY forms
dimers in solution, in a concentration-dependent manner.
3.3. Fold comparison with other proteins
A DALI [29] search revealed that the protein fold of PRY-
SPRY is most similar to the carbohydrate recognition domain
of the ER folding chaperone p58/ERGIC-53 [30], belonging to
the agglutinin family (Table 2). In spite of the low sequence
identity, usually below 10%, PRYSPRY and the proteins of
the top DALI hits share the same core b-sandwich architec-
ture, that of a jelly roll topology (CATH, [31]). Interestingly,
in pea lectin [30], a homologue of the CRD of p58/ERGIC-
53, an extended binding pocket is located on the concave side
of the b-sheet as we see in the PRYSPRY-domain (Fig. 3B).
3.4. Alignment and mutation models of Pyrin and TRIM5a
‘‘PRYSPRY’’
A ClustalX alignment [26] of 15 PRYSPRY sequences
showed that the PRYSPRY-domain can be found in several
protein families (Fig. 4). These families can be divided into ﬁve
groups depending on sequence motifs present before or after
the PRYSPRY-domain. Families 2–4 share the highest identity
to human PRYSPRY-19q13.4.1 both in the PRY and in the
SPRY segments. The PRY segment of TRIM5a is only dis-
tantly related to the PRY segment of PRYSPRY and SSB2
contains no PRY segment at all. They are similar only in the
SPRY segment. The average identity for the SPRY segment
in all families is 20%.
Based on the PRYSPRY structure we created models of the
PRYSPRY domains of Pyrin and of TRIM5a to locate muta-
tions causing the FMF disease (involving Pyrin mutations,
http://fmf.igh.cnrs.fr/, [32]) and HIV-1 restriction (involving a
single mutation in TRIM5a, [12]). Mutations responsible for
Fig. 4. Multiple sequence alignment of proteins containing a SPRY segment (generated with ClustalX [26]). Proteins are grouped by family.
Accession numbers: PRYSPRY (human, EST database no. CA454993), xlNF7 (Xenopus leavis, UP: Q92021), huPYRIN (human, UP: O15553),
huRFP (human, UP: P14373), pwA33 (Pleurodeles waltlii, UP: Q02084), huB30RFP (human, UP: Q9UDY6), huEBBP (human, UP: O95361),
huEFP (human, UP: Q14258), huTRIM5 (human, UP: Q9CO35), huBTN (human, UP: Q13410), boBTN (bovine, UP: P18892), cpENT1 (Cavia
porcellus, UP: Q99PR5), shSNTXa (Synanceia horrida, UP: Q98989), shSNTXb (Synanceia horrida, UP: Q91453) and moSSB2 (mouse, UP:
O88838). Sequence alignment was colored according to the properties of the amino-acids using the default values of CHROMA (for chromatic
representation of multiple alignments) [40]. Conserved residues appear in the same color.
Table 3
List of mutations with disease related symptoms in the PRYSPRY-domain of Pyrin
Residue 591 653 675 680 680 681 692 694 694 694 695 726 744 761
Mutation Iﬁ T RﬁH Sﬁ N Mﬁ I Mﬁ L Tﬁ I Missing Mﬁ I Mﬁ V Missing Kﬁ R Vﬁ A Aﬁ S Rﬁ H
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Fig. 5. (A) Surface representation of the PRYSPRY-domain (accep-
tor). Residues interacting with the donor PRYSPRY-domain are
mapped in purple. (B) Model of the PRYSPRY-domain of PYRIN.
Residues involved in the FMF disease are mapped in yellow.
C. Gru¨tter et al. / FEBS Letters 580 (2006) 99–106 105the FMF disease (Table 3, Fig. 5B), mapped onto the Pyrin-
PRYSPRY model, surprisingly cluster in loops belonging to
the putative PRYSPRY-binding site, aﬀecting binding to un-
known target proteins (Fig. 5A and B). This supports our pro-
posal of a ligand-binding function for the previously deﬁned
interaction site of PRYSPRY (Fig. 3A, C, and D). In contrast,
the mutation leading to HIV-1 restriction in TRIM5a is located
outside the putative binding pocket of the PRYSPRY-domain,
namely in the PRY segment. Furthermore, the PRY segment of
TRIM5a and PRYSPRY are only distantly related, suggesting
that the interaction mechanism of TRIM5a is diﬀerent.
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